ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Impact of propofol infusion-based sedation on anesthesia-related adverse events in endoscopic ultrasonography: A prospective observational study

Caner Genc, Nevzat Gumus, Ahmet Ozan Aydin, Hatice Kusderci, Kasim Demir, Taner Akyol, Umut Emre Aykut, Ozgur Komurcu.



Abstract
Download PDF Post

Procedural sedation is recommended for endoscopic ultrasonography (EUS) to enhance patient comfort and optimize procedural conditions. This study aimed to evaluate the impact of continuous propofol infusion as the main component of the sedation protocol on anesthesia-related adverse events during EUS. This single-center observational prospective cohort study was conducted in the endoscopy unit of a territorial hospital. Seventy-five patients were enrolled from April 24 to June 24, 2024. The sedation protocol included intravenous administration of midazolam (0.02 mg/kg), propofol (0.5 mg/kg), and ketamine (0.25 mg/kg), followed by continuous propofol infusion for anesthesia maintenance. Standard monitoring, the Bispectral Index (BIS), and non-invasive end-tidal CO2 monitoring were applied. Adverse events were defined as arrhythmias, bradycardia (HR

Key words: Non-operating room anesthesia, endoscopic ultrasonography, procedural sedation, propofol infusion, patient safety, adverse events







Bibliomed Article Statistics

10
10
11
19
17
4
R
E
A
D
S

10

6

11

20

22

3
D
O
W
N
L
O
A
D
S
091011120102
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.